SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-22-027670
Filing Date
2022-05-17
Accepted
2022-05-17 16:37:11
Documents
2
Group Members
DAVID S. RICHMONDMATTHEW J. CURFMANRBI OPPORTUNITIES FUND II, LLCRBI OPPORTUNITIES FUND, LLCRBI PRIVATE INVESTMENT III, LLCRICHMOND BROTHERS 401(K) PROFIT SHARING PLAN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea160048-13grich_ocuphire.htm SC 13G 112268
2 JOINT FILING AGREEMENT ea160048ex99-1_ocuphire.htm EX-99.1 10602
  Complete submission text file 0001213900-22-027670.txt   124836
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Subject) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79996 | Film No.: 22935109
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7415 FOXWORTH COURT JACKSON MI 49201
Business Address 7415 FOXWORTH COURT JACKSON MI 49201 517-536-5000
Richmond Brothers, Inc. (Filed by) CIK: 0001540462 (see all company filings)

IRS No.: 205152300 | State of Incorp.: MI | Fiscal Year End: 1231
Type: SC 13G